v3.26.1
Stockholders' Equity and Stock-based Compensation (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Stock Option Activity
A summary of the Company’s stock option activity during the three months ended March 31, 2026 is as follows:
Outstanding OptionsWeighted Average Exercise
Price		Weighted Average Remaining
Contractual Life		Aggregate Intrinsic Value
(in thousands)(Years)(in thousands)
Balance as of December 31, 20251,186$127.50 7.0$13,453 
Granted62$127.52 
Exercised(10)$33.24 
Canceled(23)$136.49 
Balance as of March 31, 20261,215$128.09 6.9$1,252 
Vested and expected to vest as of March 31, 20261,107$127.54 6.7$1,252 
Exercisable as of March 31, 2026774$124.19 5.8$1,252 
Schedule of RSU Activity Inclusive of PRSU Activity
A summary of the Company’s RSU activity, inclusive of PRSU activity, during the three months ended March 31, 2026 is as follows:
Outstanding RSUsWeighted Average Grant Date Fair Value
Per Share
(in thousands)
Balance as of December 31, 20251,148(1)$133.74 
Granted242(2)$127.52 
Vested(182)(3)$137.56 
Forfeited(86)(4)$138.74 
Balance as of March 31, 20261,122(5)$131.39 
Outstanding and expected to vest as of March 31, 2026863$131.58 
(1)Included 165 thousand PRSUs granted to certain executive officers in 2025, 2024 and 2022.
(2)Included 201 thousand PRSUs granted to certain executive officers in the three months ended March 31, 2026.
(3)Included 91 thousand PRSUs granted to certain executive officers in 2025 and 2022.
(4)Included 53 thousand PRSUs granted to certain executive officers in 2025.
(5)Included 222 thousand PRSUs granted to certain executive officers in 2026, 2025 and 2024.
Schedule of Stock-Based Compensation Expense in Statements of Operations
The following table shows a summary of the stock-based compensation expenses included in the condensed consolidated statements of operations:
Three Months Ended
March 31,
20262025
(in thousands)
Cost of revenues$2,061 $2,090 
Research and development4,608 5,104 
Sales and marketing4,189 3,200 
General and administrative8,482 8,426 
Total stock-based compensation, net of amounts capitalized (1)$19,340 $18,820 
(1)Total stock-based compensation expense capitalized was de minimis during the three months ended March 31, 2026 and 2025.
Schedule of Share Repurchase Program
The Company's share repurchase program was authorized by the board of directors as follows:
Announcement DateAuthorized Dollar Value
(in millions)
February 12, 2018$100.0 
October 30, 2018100.0 
October 30, 2019100.0 
May 7, 2020100.0 
February 10, 2021100.0 
November 3, 2021200.0 
May 4, 2022200.0 
February 9, 2023100.0 
February 7, 2024200.0 
February 6, 2025200.0 
February 5, 2026200.0 
Total as of March 31, 2026$1,600.0